T-knife is a fast-growing, pre-clinical-stage biopharmaceutical company developing tumor-specific T cell receptor (TCR) therapies.

Biotechnology

T-knife

T-knife's headquarters in Berlin, Germany

The San Francisco office focuses on executive leadership, financial management, and administrative support for key executives.

San Francisco

Thomas Soloway

Nicole Norris

Peggy Sotiropoulou

Danielle Delorio

Ron Krasnow

Camille Landis

Elisa Kieback

Olivier Litzka

Thomas Blankenstein

Debasish Roychowdhury

Alexander Mayweg

Josh Resnick

John B. Haanen

Richard P. Junghans

Karin Kleinhans

Fiona Thistlethwaite

Geraldine O'Keeffe

Laura Brege

The Research and Development Team at T-knife is responsible for driving innovation in tumor-specific T cell receptor (TCR) therapies. This multidisciplinary team of scientists and research professionals collaborates to discover, develop, and optimize novel TCRs, ensuring the efficacy and safety of therapies in pre-clinical stages. They utilize cutting-edge techniques and data analysis to advance the company’s therapeutic pipeline, ultimately aiming to improve treatment outcomes in cancer patients.

Research and Development Team

The Leadership Team at T-knife drives strategic decision-making and oversees the company’s operations to advance the development of tumor-specific T cell receptor therapies. Comprising experts in business, finance, technology, manufacturing, and scientific research, the team collaborates to align resources, set organizational goals, and ensure the successful transition from pre-clinical development to clinical trials. Their collective vision aims to position T-knife as a leader in innovative biopharmaceutical solutions.

Leadership Team

The Scientific Research Team at T-knife is dedicated to advancing the development of tumor-specific T cell receptor therapies. Comprised of experts across various scientific disciplines, the team conducts pivotal research, designs preclinical studies, and ensures the scientific rigor of therapeutic candidates, ultimately driving innovative solutions for cancer treatment. Their collaborative efforts support the strategic direction of the company while fostering a culture of scientific excellence.

Scientific Research Team

This department oversees the strategic direction and policies set by the board of directors.

Board Governance

The Finance and Accounting team at T-knife is responsible for managing the company's financial health and supporting its strategic growth. This includes overseeing budgeting, financial reporting, and regulatory compliance, as well as ensuring timely processing of accounts payable. The team works closely with leadership to allocate resources effectively and provide financial insights that guide decision-making in the development of innovative TCR therapies.

Finance and Accounting

This department focuses on scientific research and innovation to advance products and solutions.

T-knife

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Scientific Research Team

Board Governance

Finance and Accounting

Research and Development

Offices

T-knife

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Scientific Research Team

Board Governance

Finance and Accounting

Research and Development

Offices

Related companies